抗人血小板抗原-5b抗体与胎儿及新生儿同种免疫性血小板减少症:偶然关联还是因果关系?
本综述按PRISMA指南检索MEDLINE数据库,分析抗HPA-5b抗体与胎儿及新生儿同种免疫性血小板减少症(FNAIT)的关系,并回顾性分析单中心817例疑似FNAIT病例。未选择欧洲孕妇中抗HPA-5b抗体合并患病率为1.96%(n=3113),疑似FNAIT孕妇为3.4%(n=5003);有无母体抗HPA-5b抗体的疑似FNAIT病例新生儿血小板计数无差异。现有实验与流行病学证据不支持抗HPA-5b抗体导致胎儿或新生儿严重血小板减少或出血并发症的假说。
要点
- 未选择欧洲孕妇抗HPA-5b抗体合并患病率为1.96%(n=3113),疑似FNAIT孕妇为3.4%(n=5003)。
- 有无母体抗HPA-5b抗体的疑似FNAIT病例(n=817)新生儿血小板计数无差异。
- 颅内出血新生儿与健康对照的母体抗HPA-5b抗体患病率无差异。
核心结论
- 现有实验与流行病学证据不支持抗HPA-5b抗体导致胎儿或新生儿严重血小板减少或出血并发症的假说。
- 仅有微弱证据提示小部分携带抗HPA-5b抗体的孕妇可能分娩轻度血小板减少的新生儿。
研究设计与样本
- 按PRISMA指南检索MEDLINE数据库的文献综述。
- 单中心817例疑似FNAIT病例的回顾性分析。
主要发现
- 未选择欧洲孕妇抗HPA-5b抗体合并患病率为1.96%(n=3113),疑似FNAIT孕妇为3.4%(n=5003)。
- 有无母体抗HPA-5b抗体的疑似FNAIT病例(n=817)新生儿血小板计数无差异。
- 颅内出血新生儿与健康对照的母体抗HPA-5b抗体患病率无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most cases of fetal and neonatal thrombocytopenia (FNAIT) are caused by maternal anti-human platelet antigen-1a antibodies (anti-HPA-1a). Anti-HPA-5b antibodies are the second most common antibodies in suspected FNAIT cases. Given the high prevalence of anti-HPA-5b antibodies in pregnant women delivering healthy newborns, the association with FNAIT may be coincidental. This review of the literature related to FNAIT using the MEDLINE database was conducted according to PRISMA guidelines. A retrospective analysis of a single-centre cohort of 817 suspected FNAIT cases was conducted. The pooled prevalence of anti-HPA-5b antibodies in unselected pregnant women of European descent was 1.96% (n = 3113), compared with 3.4% (n = 5003) in women with suspected FNAIT. We found weak evidence that a small proportion of pregnant women presenting with anti-HPA-5b antibodies will give birth to a newborn with mild thrombocytopenia. The neonatal platelet counts were not different between suspected FNAIT cases (n = 817) with and without maternal anti-HPA-5b antibodies. The prevalence of maternal anti-HPA-5b antibodies was not different between neonates with intracranial haemorrhage and healthy controls. The current experimental and epidemiological evidence does not support the hypothesis that anti-HPA-5b antibodies cause severe thrombocytopenia or bleeding complications in the fetus or newborn.
引用
- Alm J, Duong Y, Wienzek-Lischka S, et al. Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect? Br J Haematol. 2022. PMID: 35383895. doi:10.1111/bjh.18173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。